Digital Media briefs: October 2012

Share this article:
Digital Media briefs: October 2012
Digital Media briefs: October 2012

The medical social network Doximity has raised $17 million in series B financing, reported MedCity News. CEO Jeff Tangney told the publication the money would be used to “scale the network and expand our offerings.” The company's network provides a secure environment in which professionals can discuss patient cases and exchange patient information. Doximity says 1 in 7 US doctors are in its network.

Eli Lilly released a diabetes app Tuesday that is aimed at educating caregivers. The Lilly Glucagon Mobile App is designed for iPhones and iPads and teaches users how to inject Glucagon into type 1 diabetics as well as provides background information about how Glucagon helps patients manage diabetes. The injection is for severe hypoglycemia.

Healthcare agency and platform developer InTouch Solutions partnered with marketing firm MD Mindset to deliver a joint set of services. Wendy Blackburn, InTouch EVP, told MM&M the collaboration is in its defining stages, but that the relationship will allow the two companies to offer their complementary skill sets to clients in tandem, or to introduce each other's capabilities as client needs arise.
Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in Features

Email Newsletters

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Features

Is your marketing strategy stuck in 2005?

Is your marketing strategy stuck in 2005?

It is not enough to just have a killer black book or Rolodex. The market needs agile, swift marketing

Is guidance stifling social media?

Recent FDA draft guidance was meant to help companies create FDA-compliant tweets and handle third-party misinformation on the web. What other obstacles lie in the path of effective social media use?

FDA social media guides draw flak

FDA social media guides draw flak

Two FDA guidance documents on how health product manufacturers may participate in social media have drawn criticism from industry and consumer groups.